NHS England has formally intervened at East Kent Hospitals University NHS Foundation Trust after an attempt by the trust's chair to suspend its chief executive without board authority triggered a governance crisis that regulators concluded the organisation could not resolve independently.
Annette Doherty, who held the chair position, resigned following findings that she had acted outside the legal and procedural mandate available to her under the trust's constitution. The attempt to suspend Chief Executive Tracey Fletcher was made without the board consensus required for such a decision, and without the legal authority the constitution vests in the board collectively rather than in the chair acting unilaterally. Fletcher has been formally reinstated, and NHS England is now directly overseeing the relationship between the executive team and the remaining non-executive directors.
The intervention represents a formal escalation of regulatory involvement rather than a continuation of standard oversight. Under NHS England's national oversight framework, a formal intervention at this level grants the regulator direct authority over board appointments and strategic decision-making. East Kent remains at the highest tier of that framework, a designation equivalent to special measures for leadership, which it had occupied prior to this episode. The governance breakdown has not moved the trust to a new category of concern so much as it has confirmed that the existing concerns were not being addressed by the board in place.
The timing carries particular weight given the trust's recent history. East Kent was the subject of the Kirkup Inquiry, which examined serious failings in the trust's maternity services and found that avoidable harm had occurred over a prolonged period. The inquiry's findings placed the trust under sustained pressure to demonstrate that its clinical culture and safety practices had changed. That work requires consistent senior leadership attention and a stable governance environment in which clinical improvement programmes can be maintained and monitored. The boardroom dispute has consumed the attention of both the executive and non-executive leadership at a point when neither could afford the distraction.
The internal atmosphere at the trust has been affected by repeated leadership instability over several years. Recruiting and retaining senior clinical and managerial staff to organisations carrying this level of regulatory designation and reputational difficulty is consistently challenging. Each episode of visible governance failure reinforces the perception that the trust has not yet stabilised, making the recruitment problem harder to solve and the cultural reform that the Kirkup Inquiry identified as necessary more difficult to sustain. Staff working in clinical roles are acutely aware of leadership turbulence at board level, and the connection between boardroom stability and frontline morale is not indirect.
The specific nature of what occurred at board level raises questions beyond the immediate personnel decisions. A chair who acts to remove a chief executive without board authority has either misunderstood the legal framework within which she was operating or concluded that the circumstances justified acting outside it. Neither explanation reflects well on the governance culture of the board, and NHS England's intervention implies a judgement that the remaining board membership is not currently in a position to provide adequate oversight without external support.
The recurring difficulty of stabilising leadership at trusts in this position is a structural problem that individual interventions address only partially. NHS England can appoint or approve new board members and can oversee decision-making, but it cannot quickly rebuild the institutional trust required for an effective board to function. That process takes time that the trust's clinical improvement obligations do not readily allow for.
The intervention is a necessary regulatory response to a situation that had become unmanageable internally. Whether it produces the stable platform needed to make meaningful progress on the clinical and cultural reforms the trust is required to deliver will depend on the quality of the appointments made to replace the departed chair and on the willingness of the remaining board and executive team to operate within the governance structures that the trust's constitution requires. The regulator can impose stability in formal terms. It cannot manufacture the organisational cohesion that East Kent has repeatedly struggled to sustain.
